6.
Luo Y, Lan C, Li H, Ouyang Q, Kong F, Wu A
. Rational consideration of Akkermansia muciniphila targeting intestinal health: advantages and challenges. NPJ Biofilms Microbiomes. 2022; 8(1):81.
PMC: 9576740.
DOI: 10.1038/s41522-022-00338-4.
View
7.
Baldelli V, Scaldaferri F, Putignani L, Del Chierico F
. The Role of Enterobacteriaceae in Gut Microbiota Dysbiosis in Inflammatory Bowel Diseases. Microorganisms. 2021; 9(4).
PMC: 8066304.
DOI: 10.3390/microorganisms9040697.
View
8.
Laursen M, Larsson M, Lind M, Larnkjaer A, Molgaard C, Michaelsen K
. Intestinal Enterococcus abundance correlates inversely with excessive weight gain and increased plasma leptin in breastfed infants. FEMS Microbiol Ecol. 2020; 96(5).
PMC: 7183236.
DOI: 10.1093/femsec/fiaa066.
View
9.
Trakman G, Fehily S, Basnayake C, Hamilton A, Russell E, Wilson-OBrien A
. Diet and gut microbiome in gastrointestinal disease. J Gastroenterol Hepatol. 2021; 37(2):237-245.
DOI: 10.1111/jgh.15728.
View
10.
Magne F, Gotteland M, Gauthier L, Zazueta A, Pesoa S, Navarrete P
. The Firmicutes/Bacteroidetes Ratio: A Relevant Marker of Gut Dysbiosis in Obese Patients?. Nutrients. 2020; 12(5).
PMC: 7285218.
DOI: 10.3390/nu12051474.
View
11.
Portincasa P, Khalil M, Graziani A, Fruhbeck G, Baffy G, Garruti G
. Gut microbes in metabolic disturbances. Promising role for therapeutic manipulations?. Eur J Intern Med. 2023; 119:13-30.
DOI: 10.1016/j.ejim.2023.10.002.
View
12.
Hansen T, Thomassen M, Madsen M, Kern T, Bak E, Kashani A
. The effect of drinking water pH on the human gut microbiota and glucose regulation: results of a randomized controlled cross-over intervention. Sci Rep. 2018; 8(1):16626.
PMC: 6226457.
DOI: 10.1038/s41598-018-34761-5.
View
13.
Aziz I, Palsson O, Tornblom H, Sperber A, Whitehead W, Simren M
. Epidemiology, clinical characteristics, and associations for symptom-based Rome IV functional dyspepsia in adults in the USA, Canada, and the UK: a cross-sectional population-based study. Lancet Gastroenterol Hepatol. 2018; 3(4):252-262.
DOI: 10.1016/S2468-1253(18)30003-7.
View
14.
Liu B, Liu X, Liang Z, Wang J
. Gut microbiota in obesity. World J Gastroenterol. 2021; 27(25):3837-3850.
PMC: 8291023.
DOI: 10.3748/wjg.v27.i25.3837.
View
15.
Yamawaki H, Futagami S, Wakabayashi M, Sakasegawa N, Agawa S, Higuchi K
. Management of functional dyspepsia: state of the art and emerging therapies. Ther Adv Chronic Dis. 2018; 9(1):23-32.
PMC: 5761940.
DOI: 10.1177/2040622317725479.
View
16.
Yibirin M, de Oliveira D, Valera R, Plitt A, Lutgen S
. Adverse Effects Associated with Proton Pump Inhibitor Use. Cureus. 2021; 13(1):e12759.
PMC: 7887997.
DOI: 10.7759/cureus.12759.
View
17.
Jin J, Cheng R, Ren Y, Shen X, Wang J, Xue Y
. Distinctive Gut Microbiota in Patients with Overweight and Obesity with Dyslipidemia and its Responses to Long-term Orlistat and Ezetimibe Intervention: A Randomized Controlled Open-label Trial. Front Pharmacol. 2021; 12:732541.
PMC: 8426637.
DOI: 10.3389/fphar.2021.732541.
View
18.
Guo P, Zhang K, Ma X, He P
. species as probiotics: potentials and challenges. J Anim Sci Biotechnol. 2020; 11:24.
PMC: 7031906.
DOI: 10.1186/s40104-019-0402-1.
View
19.
Wang R, Li Z, Liu S, Zhang D
. Global, regional, and national burden of 10 digestive diseases in 204 countries and territories from 1990 to 2019. Front Public Health. 2023; 11:1061453.
PMC: 10088561.
DOI: 10.3389/fpubh.2023.1061453.
View
20.
Ignacio A, Fernandes M, Rodrigues V, Groppo F, Cardoso A, Avila-Campos M
. Correlation between body mass index and faecal microbiota from children. Clin Microbiol Infect. 2015; 22(3):258.e1-8.
DOI: 10.1016/j.cmi.2015.10.031.
View